291 related articles for article (PubMed ID: 20444857)
1. Assessment of patients with primary Sjögren's syndrome--outcome over 10 years using the Sjögren's Syndrome Damage Index.
Krylova L; Isenberg D
Rheumatology (Oxford); 2010 Aug; 49(8):1559-62. PubMed ID: 20444857
[TBL] [Abstract][Full Text] [Related]
2. Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients.
Vitali C; Palombi G; Baldini C; Benucci M; Bombardieri S; Covelli M; Del Papa N; De Vita S; Epis O; Franceschini F; Gerli R; Govoni M; Bongi SM; Maglione W; Migliaresi S; Montecucco C; Orefice M; Priori R; Tavoni A; Valesini G
Arthritis Rheum; 2007 Jul; 56(7):2223-31. PubMed ID: 17599741
[TBL] [Abstract][Full Text] [Related]
3. Autonomic nervous dysfunction development in patients with primary Sjogren's syndrome: a follow-up study.
Mandl T; Hammar O; Theander E; Wollmer P; Ohlsson B
Rheumatology (Oxford); 2010 Jun; 49(6):1101-6. PubMed ID: 20219783
[TBL] [Abstract][Full Text] [Related]
4. Non-Hodgkin's lymphoma associated with primary Sjögren's syndrome.
Pariente D; Anaya JM; Combe B; Jorgensen C; Emberger JM; Rossi JF; Sany J
Eur J Med; 1992 Oct; 1(6):337-42. PubMed ID: 1341461
[TBL] [Abstract][Full Text] [Related]
5. Increased severity of lower urinary tract symptoms and daytime somnolence in primary Sjögren's syndrome.
Walker J; Gordon T; Lester S; Downie-Doyle S; McEvoy D; Pile K; Waterman S; Rischmueller M
J Rheumatol; 2003 Nov; 30(11):2406-12. PubMed ID: 14677185
[TBL] [Abstract][Full Text] [Related]
6. The Sjögren's Syndrome Damage Index--a damage index for use in clinical trials and observational studies in primary Sjögren's syndrome.
Barry RJ; Sutcliffe N; Isenberg DA; Price E; Goldblatt F; Adler M; Canavan A; Hamburger J; Richards A; Regan M; Gadsby K; Rigby S; Jones A; Mathew R; Mulherin D; Stevenson A; Nightingale P; Rauz S; Bowman SJ
Rheumatology (Oxford); 2008 Aug; 47(8):1193-8. PubMed ID: 18524804
[TBL] [Abstract][Full Text] [Related]
7. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H
Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
[TBL] [Abstract][Full Text] [Related]
8. Pure sensory neuropathy in primary Sjögren's syndrome. Longterm prospective followup and review of the literature.
Font J; Ramos-Casals M; de la Red G; Pou A; Casanova A; García-Carrasco M; Cervera R; Molina JA; Valls J; Bové A; Ingelmo M; Graus F
J Rheumatol; 2003 Jul; 30(7):1552-7. PubMed ID: 12858457
[TBL] [Abstract][Full Text] [Related]
9. [Long-term follow-up of 43 patients with Sjögren's syndrome].
Cui G; Sugai S; Ogawa Y; Takeshita S; Masaki Y; Fukutoku M
Ryumachi; 1997 Dec; 37(6):770-80. PubMed ID: 9492564
[TBL] [Abstract][Full Text] [Related]
10. Association between primary Sjögren's syndrome and non-Hodgkin's lymphoma.
Opriş D; Iosif CI; Predeţeanu D
Rom J Intern Med; 2004; 42(4):715-23. PubMed ID: 16366143
[TBL] [Abstract][Full Text] [Related]
11. Articular manifestations in primary Sjögren's syndrome: clinical significance and prognosis of 188 patients.
Fauchais AL; Ouattara B; Gondran G; Lalloué F; Petit D; Ly K; Lambert M; Launay D; Loustaud-Ratti V; Bezanahari H; Liozon E; Hachulla E; Jauberteau MO; Vidal E; Hatron PY
Rheumatology (Oxford); 2010 Jun; 49(6):1164-72. PubMed ID: 20299380
[TBL] [Abstract][Full Text] [Related]
12. Primary Sjögren's syndrome activity and damage indices comparison.
Campar A; Isenberg DA
Eur J Clin Invest; 2010 Jul; 40(7):636-44. PubMed ID: 20482595
[TBL] [Abstract][Full Text] [Related]
13. Clinical features distinguishing lymphoma development in primary Sjögren's Syndrome--a retrospective cohort study.
Risselada AP; Kruize AA; Bijlsma JW
Semin Arthritis Rheum; 2013 Oct; 43(2):171-7. PubMed ID: 23664530
[TBL] [Abstract][Full Text] [Related]
14. Sleepiness or fatigue? Can we detect treatable causes of tiredness in primary Sjögren's syndrome?
Theander L; Strömbeck B; Mandl T; Theander E
Rheumatology (Oxford); 2010 Jun; 49(6):1177-83. PubMed ID: 20308122
[TBL] [Abstract][Full Text] [Related]
15. Primary Sjogren's syndrome in men.
Gondran G; Fauchais A; Lambert M; Ly K; Launay D; Queyrel V; Benazahari H; Liozon E; Loustaud-Ratti V; Hachulla E; Jauberteau M; Hatron P; Vidal E
Scand J Rheumatol; 2008; 37(4):300-5. PubMed ID: 18612931
[TBL] [Abstract][Full Text] [Related]
16. Sjögren's syndrome in patients with newly diagnosed untreated non-Hodgkin's lymphoma.
Andonopoulos AP; Tiniakou M; Melachrinou M; Sfountouris H; Bounas A; Zervas C; Zoumbos NC
Rev Rhum Engl Ed; 1997 May; 64(5):287-92. PubMed ID: 9190001
[TBL] [Abstract][Full Text] [Related]
17. Clinical course of primary Sjögren's syndrome: salivary, oral, and serologic aspects.
Gannot G; Lancaster HE; Fox PC
J Rheumatol; 2000 Aug; 27(8):1905-9. PubMed ID: 10955331
[TBL] [Abstract][Full Text] [Related]
18. Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximab.
Meiners PM; Arends S; Brouwer E; Spijkervet FK; Vissink A; Bootsma H
Ann Rheum Dis; 2012 Aug; 71(8):1297-302. PubMed ID: 22258489
[TBL] [Abstract][Full Text] [Related]
19. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
[TBL] [Abstract][Full Text] [Related]
20. Malignant lymphoma in primary Sjogren's syndrome.
Voulgarelis M; Moutsopoulos HM
Isr Med Assoc J; 2001 Oct; 3(10):761-6. PubMed ID: 11692552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
